$AKBA selectionnewyork.blogspot.c... šŸ‘† _________________ We believe this could translate into a potential $2 billion market opportunity in the U.S. alone. We are equally excited with vadadustat's opportunity in dialysis beyond the U.S. market, and we're working in close collaboration with Otsuka to prepare a marketing authorization application, or MAA, for submission to the European Medicines Agency next year following our NDA. _________________ Our team is leading Akebia through the most dynamic period in its history. And importantly, we believe we're positioning Akebia to deliver on a strategy that we believe will build long-term value for our shareholders. ____________ selectionnewyork.blogspot.c... šŸ‘‡